Cataracts in diabetic patients: A review article

Journal of Ophthalmic and Vision Research

Volumn 3, Issue 1, 2008, Pages 52-65

  Javadi, Mohammad Ali ^a   Zarei Ghanavati, Siamak ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875441508     PISSN: 20082010     EISSN: 2008322X     Source Type: Journal    
DOI: None     Document Type: Review

References (109)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053.
2. World Health Organization. http://www.who.int/blindness/causes. Accessed 7 September 2006.
3. Klein BE, Klein R, Moss SE. Incidence of cataract surgery in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Am J Ophthalmol 1995;119:295-300.
4. Klein BE, Klein R, Wang Q, Moss SE. Older-onset diabetes and lens opacities. The Beaver Dam Eye Study. Ophthalm Epid 1995;2:49-55.
5. Hamilton AM, Ulbig MW and Polkinghorne P. Epidemiology of diabetic retinopathy. In: Hamilton AM, Ulbig MW and Polkinghorne P Management of Diabetic Retinopathy. London: BMJ Publishing Group; 1996: 1-15.
6. Klein BE, Klein R, Moss MS. Prevalence of cataracts in a population-based study of persons with diabetes mellitus. Ophthalmology 1985;92:1191-1196.
7. Klein R, Klein BE, Moss MS. Visual impairment in diabetics. Ophthalmology 1984;91:1-8.
8. Aiello LM, Wand M, Liang G. Neovascular glaucoma and vitreous hemorrhage following cataract surgery in patients with diabetes mellitus. Ophthalmology 1983;90:814-820.
9. Poliner LS, Christianson DJ, Escoffery RF, Kolker AE, Gordon ME. Neovascular glaucoma after intracapsular and extracapsular cataract extraction in diabetic patients. Am J Ophthalmol 1985;100:637-643.
10. Jaffe GJ, Burton TC, Kuhn E, Prescott A, Hartz A. Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation. Am J Ophthalmol 1992; 114:448-456.
11. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl Med 1993;329:977-986.
12. United Kingdom Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853.
13. Aiello L, Cahill M, Wong J. Systemic considerations in the management of diabetic retinopathy. Am J Ophthalmol 2001;132:760-776.
14. Kato S, Shiokawa A, Fukushima H, Numaga J, Kitano S, Hori S, et al. Glycemic control and lens transparency in patients with type 1 diabetes mellitus. A m J Ophthalmol 2001;131:301-304.
15. Kato S, Oshika T, Numaga J, Kawashima H, Kitano S, Kaiya T. Influence of rapid glycemic control on lens opacity in patients with diabetes mellitus. Am J Ophthalmol 2000;130:354-355.
16. Bernth-Peterson P, Bach E. Epidemiologic aspects of cataract surgery. Frequencies of diabetes and glaucoma in a cataract population. Acta Ophthalmol 1983;61:406-416.
17. Saxena S, Mitchell P, Rochtchina E. Five-year incidence of cataract in older persons with diabetes and pre-diabetes. Ophthalm Epid 2004;11:271-277.
18. Janghorbani M, Amini M. Cataract in type 2 diabetes mellitus in Isfahan, Iran: Incidence and risk factors. Ophthalm Epid 2004;11:347-358.
19. Kyselova Z, Stefek M, Bauer V. Pharmacological prevention of diabetic cataract. J Diabetes Complications 2004;18:129-140.
20. Didenko TN, Smoliakova GP, Sorokin EL, Egorov VV. Clinical and pathogenetic features of neurotrophic corneal disorders in diabetes. Vestn Oftalmol. 1999;115:7-11.
21. Saini JS, Khandalavla B. Corneal epithelial fragility in diabetes mellitus. Can J Ophthalmol 1995;30:142-146.
22. Sanchez-Thorin JC. The cornea in diabetes mellitus. Int Ophthalmol Clin 1998;38:19-36.
23. Herse PR. A review of manifestations of diabetes mellitus in the anterior eye and cornea. Am J Optom Physiol Opt 1988;65:224-230.
24. McNamara NA, Brand RJ, Polse KA, Bourne WM. Corneal function during normal and high serum glucose levels in diabetes. Invest Ophthalmol Vis Sci 1998;39:3-17.
25. Touzeau O, Levet L, Borderie V, Bouchard P, Laroche L. Anterior segment of the eye and diabetes mellitus. J Fr Ophthalmol 2004;27:859-870.
26. Stolwijk TR, van Best JA, Oosterhuis JA, Swart W. Corneal autofluorescence, an indicator of diabetic retinopathy. Invest Ophthalmol Vis Sci 1992;33:92-97.
27. Schultz RO, Van Horn DL, Peters MA, Klewin KM, Schutten WH. Diabetic keratopathy. Trans Am Ophthalmol Soc 1981;79:180-199.
28. Gekka M, Miyata K, Nagai Y, Nemoto S, Sameshima T, Tanabe T, et al. Corneal epithelial barrier function in diabetic patients. Cornea 2004;23:35-37.
29. Saini JS, Mittal S. In vivo assessment of corneal endothelial function in diabetes mellitus. Arch Ophthalmol 1996;114:649-653.
30. Mehmet M, Irfan D, Murat I and Mehmet O. Morphologic alterations of both the stromal and subbasal nerves in the corneas of patients with diabetes. Cornea 2006;25:769-773.
31. Quadrado MJ, Popper M, Morgado AM, Murta JN, Van Best JA. Diabetes and corneal cell densities in humans by in vivo confocal microscopy. Cornea 2006;25:761-768.
32. Inoue K, Kato S, Inoue Y, Amano S, Oshika T. The corneal endothelium and thickness in type II diabetes mellitus. Jpn J Ophthalmol 2002;46:65-69.
33. TG Ramsel. Lens capsule in diabetics. Br J Ophtalmol1969;53:98.
34. Schäfer C, C Lautenschläger, HG Struck. Cataract types in diabetics and non-diabetics: a densitometric study with the Topcon-Scheimpflug camera. Klin Monatsbl Augenheilkd 2006;223:589-592.
35. Orts Vila P, Devesa Torregrosa P, Belmonte Martínez J. Juvenile diabetic cataract. A rare finding that lead us to the diagnosis of this illness. Arch Soc Esp Oftalmol 2003;78:389-391.
36. Yanoff M, Fine BS, Berkow JW. Diabetic lacy vacuolation of iris pigment epithelium: histopathologic report. Am J Ophthalmol 1970;69:201.
37. Voutilainen-Kaunisto R, Niskanen L, Uusitupa M, Teräsvirta M. Iris transluminance in type 2 diabetes. Acta Ophthalmol Scand 2002;80:64-68.
38. Peponis V, Bonovas S, Filioussi K. Diabetes mellitus as a risk factor for primary open-angle glaucoma: a meta-analysis. Diabet Med 2004;21:609-614.
39. Mitchell P, Smith W, Chey T, Healey PR. Openangle glaucoma and diabetes:the blue mountains eye study, Australia. Ophthalmology 1977;104:712-718.
40. Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:714-720.
41. McGrath DJ, Ferguson JG, Sanborn GE. Neovascular glaucoma. Focal Points: Clinical Modules for Ophthalmologists. San Francisco: American Academy of Ophthalmology; 1997: module 7.
42. Sivak-Callcott JA, O'Day DM, Gass JD, Tsai JC. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology. 2001;108:1767-1776.
43. Pollack A, Leiba H, Bukelman A, Oliver M. Cystoid macular edema following cataract extraction in patients with diabetes. Br J Ophthalmol 1992;76:221-224.
44. Schatz H, Atienza D, McDonald HR, Johnson RN. Severe diabetic retinopathy after cataract surgery. Am J Ophthalmol 1994;117:314-321.
45. Chew EY, Benson WE, Remaley NA, Lindley AA, Burton TC, Csaky K, et al. Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25. Arch Ophthalmol 1999;117:1600-1606.
46. Dowler JG, Sehmi KS, Hykin PG, Hamilton AM. The natural history of macular edema after cataract surgery in diabetes. Ophthalmology 1999;106:663-668.
47. Minckler D, Astorino A, Hamilton AM. Cataract surgery in patients with diabetes. Ophthalmology 1998;105:949-950.
48. Pollack A, Dotan S, Oliver M. Course of diabetic retinopathy following cataract surgery. Br J Ophthalmol 1991;75:2-8.
49. Squirrell D, Bhola R, Bush J, Winder S, Talbot JF. A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes. Br J Ophthalmol 2002;86:565-571.
50. Yazdani S, Hendi K, Pakravan M. Intravitreal bevacizumab (avastin) injection for neovascular glaucoma. J Glaucoma 2007;16:437-439.
51. Chilov MN, Grigg JR, Playfair TJ. Bevacizumab (Avastin) for the treatment of neovascular glaucoma. Clin Exp Ophthalmol 2007;35:494-496.
52. Saito Y, Ohmi G, Kinoshita S, Nakamura Y, Ogawa K, Harino S, et el. Transient hyperopia with lens swelling at initial therapy in diabetes. Br J Ophthalmol 1993;77:145-148.
53. Sonmez B, Bozkurt B, Atmaca A, Irkec M, Orhan M, Aslan U. Effect of glycemic control on refractive changes in diabetic patients with hyperglycemia. Cornea 2005:24:531-537.
54. Dowler JG, Hykin PG, Hamilton AM. Phacoemulsification versus extracapsular cataract extraction in patients with diabetes. Ophthalmology 2000;107:457-462.
55. Apple DJ, Solomon KD, Tetz MR, Assia EI, Holland EY, Legler UF, et al. Posterior capsule opacification. Surv Ophthalmol 1992;37:73-116.
56. Mittra RA, Borrillo JL, Dev S, Mieler WF, Koenig SB. Retinopathy progression and visual outcomes after phacoemulsification in patients with diabetes mellitus. Arch Ophthalmol 2000;118:912-917.
57. Altug C, Gursel Y, Aydin A. Photic retinopathy after cataract surgery in diabetic patients. Retina 2006;26:1021-1028.
58. Ebihara Y, Kato S, Oshika T, Yoshizaki M, Sugita G. Posterior capsule opacification after cataract surgery in patients with diabetes mellitus. J Cataract Refract Surg 2006;32:1184-1187.
59. Nishi O, Nishi K, Wickström K. Preventing lens epithelial cell migration using intraocular lenses with sharp rectangular edges. J Cataract Refract Surg 2000;26:1543-1549.
60. Eaton AM, Jaffe GJ, McCuen BW, Mincey GJ. Condensation on the posterior surface of silicone intraocular lenses during fluid-air exchange. Ophthalmology 1995;102:733-736.
61. Kim CJ, Choi SK. Analysis of aqueous humor calcium and phosphate from cataract eyes with and without diabetes mellitus. Korean J Ophthalmol 2007;21:90-94.
62. Lee H, Seo Y, Joo CK. Progressive opacification of hydrophilic acrylic intraocular lenses in diabetic patients. J Cataract Refract Surg 2002;28:1271-1275.
63. Rodríguez-Galietero A, Montés-Micó R, Muñoz G, Albarrán-Diego C. Blue-light filtering intraocular lens in patients with diabetes: contrast sensitivity and chromatic discrimination. J Cataract Refract Surg 2005;31:2088-2092.
64. Henricsson M, Heijl A, Janzon L. Diabetic retinopathy before and after cataract surgery. Br J Ophthalmol 1996;80:789-793.
65. Antcliff RJ, Poulson A, Flanagan DW. Phacoemulsification in diabetics. Eye 1996;10:737-741.
66. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985;103:1796-1806.
67. Sebestyen JG. Intraocular lenses and diabetes mellitus. Am J Ophthalmol 1986;101:425-428.
68. Zaczek A, Olivestedt G, Zetterstrom C. Visual outcome after phacoemulsification and IOL implantation in diabetic patients. Br J Ophthalmol 1999;l83:1036-1041.
69. Mozaffarieh M, Heinzl H, Sacu S, Wedrich A. phacoemulsification cataract surgery in diabetes patients: visual function (VF-14), visual acuity and patient satisfaction. Acta Ophthalmol Scand 2005;83: 176-183.
70. Lahey JM, Francis RR, Kearney JJ. Combining phacoemulsification with pars plana vitrectomy in patients with proliferative diabetic retinopathy, a series of 223 cases. Ophthalmology 2003;110:1335-1339.
71. Scharwey K, Pavlovic S, Jacobi KW. Combined clear corneal phacoemulsification, vitreoretinal surgery, intraocular lens implantation. J Cataract Refract Surg 1999;25:693-698.
72. Amino K, Tanihara H. Vitrectomy combined with phacoemulsification and intraocular lens implantation for diabetic macular edema. Jpn J Ophthalmol 2002;46:455-459.
73. Pendergast SD, Hassan TS, Williams GA, Cox MS, Margherio RR, Ferrone PJ, et al. Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophthalmol 2000;130:178-186.
74. Harbour JW, Smiddy WE, Flynn JR, Rubsamen PE. Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 1996;121:405-413.
75. Lewis H. The role of vitrectomy in the treatment of diabetic macular edema. Am J Ophthalmol 2001;131:123-125.
76. Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema, preliminary results of a prospective controlled trial. Ophthalmology 2004;111:218-225.
77. Murtha T, Cavallerano J. The management of diabetic eye disease in the setting of cataract surgery. Curr Opin Ophthalmol 2007;18:13-18.
78. Lynch SS, CM Cheng. Bevacizumab for neovascular ocular diseases. Ann Pharmacother 2007;41:614-625.
79. Avery RL, Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology. 2006;113:1695.
80. Krupsky S, Zalish M, Oliver M, Pollack A. Anterior segment complications in diabetic patients following extracapsular cataract extraction and posterior chamber intraocular lens implantation. Ophthalmic Surg 1991;22:526-530.
81. Baltatzis S, Georgopoulos G, Theodossiadis P. Fibrin reaction after extracapsular cataract extraction: a statistical evaluation. Eur J Ophthalmol 1993;3:95-97.
82. Doft HH. The endophthalmitis vitrectomy study. In: Kertes PI. Conway MD, eds. Clinical trials in ophthalmology: a summary and practice guide. Philadelphia: Lippincott, Williams & Wilkins; 1998: 97-111.
83. Wyle{ogonek}gała E, Moćko L, Woyna-Orlewicz A, Teper S, Orzechowska-Wyle{ogonek}gała B Diabetic complications within ocular surface. Pol Merkur Lekarski 2006;21:495-497.
84. Kalpana B, Murthy N, Murthy R. Microscopy wavelike epitheliopathy after phacoemulsification: role of in vivo confocal microscopy. Cornea 2007;26:747-748.
85. Pfister RR. Clinical measasures to promote corneal epithelial healing. Acta Ophthalmol Suppl 1992;202:73-83.
86. Boisjoly HM, Beaulieu A. Topical autologous fibronectin in patients with recurrent corneal epithelial defects. Cornea 1991;10:483-488.
87. Daniele S, Frati L, Fiore C, Santoni G. The effect of the Epidermal growth factor (EGF) on the corneal epithelium in humans. Graefes Arch Clin Exoohthalmol 1979;210:159-165.
88. Lee CH, Whiteman AL, Murphy CJ, Barney NP, Taylor PB, Reid TW. Substance P, insulin like growth factor I, and surface healing. Arch Ophthalmol 2002;120:215-217.
89. Salonen EM, Tervo T, Törmä E, Tarkkanen A, Vaheri A. Plasmin in tear fluid of patient with corneal ulcers: basis for new therapy. Acta Ophthalmol 1987;65:3-12.
90. Letko E, Stechschulte SU, Kenyon KR, Sadeq N, Romero TR, Samson CM, et al. Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers. Arch Ophthalmol 2001;119:659-663.
91. Zagon IS, Klocek MS, Sassani JW, McLaughlin PJ. Topical insulin normalizes corneal reepithelialization in diabetic rats Use of topical insulin to normalize corneal epithelial healing in diabetes mellitus. Arch Ophthalmol 2007;125:1082-1088.
92. Morikubo S, Takamura Y, Kubo E, Tsuzuki S, Akagi Y. Corneal changes after small-incision cataract surgery in patients with diabetes mellitus. Arch Ophthalmol 2004;122:966-969.
93. Lee JS, Lee JE, Choi HY, Oum BS, Cho BM. Corneal endothelial cell change after phacoemulsification relative to the severity of diabetic retinopathy. J Cataract Refract Surg 2005;31:742-749.
94. Alpar JJ. Cataract extraction and diabetic retinopathy. Am Intraocul Implant Soc J 1984;10:433-437.
95. Vignanelli M. Aggravation de la retinopathie diabetique apres extraction de la cataracte. Klin Monatsbl Augenheilkd 1990;196:334-337.
96. Pollack A, Dotan S, Oliver M. Progression of diabetic retinopathy after cataract extraction. Br J Ophthalmol 1991;75:547-551.
97. Jaffe GJ, Burton TC. Progression of nonproliferative diabetic retinopathy following cataract extraction. Arch Ophthalmol 1988;106:745-749.
98. Wagner T, Knaflic D, Rauber M, Mester U. Influence of cataract surgery on the diabetic eye: a prospective study. Ger J Ophthalmol 1996;5:79-83.
99. Krepler K, Biowski R, Schrey S, Jandrasits K, Wedrich A. Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 2002;240:735-738.
100. Hauser D, Katz H, Pokroy R, Bukelman A, Shechtman E, Pollack A. Occurrence and progression of diabetic retinopathy after phacoemulsification cataract surgery. J Cataract Refract Surg 2004;30:428-432.
101. Patel J, Hykin P, Cree A. Antiangiogenic growth factors after cataract surgery, which may induce subclinical and clinical worsening of diabetic maculopathy. Br J Ophthalmol 2006;90:697-701.
102. Jurecka T, Bátková Z, Ventruba J, Synek S. Macular edema after cataract surgery in diabetic patients without retinopathy. Cesk Slov Oftalmol 2007;63:274-284.
103. Romero-Aroca P, Fernandez-Ballart J, Almena-Garcia M, Mendez-Marin I, Salvat-Serra M, Buil-Calvo JA. Nonproliferative diabetic retinopathy and macular edema progression after phacoemulsification: Prospective study. J Cataract Refract Surg 2006;32:1438-1444.
104. Pollack A, Leiba H, Bukelman A, Abrahami S, Oliver M. The course of diabetic retinopathy following cataract surgery in eyes previously treated by laser photocoagulation. Br J Ophthalmol 1992;76:228-231.
105. Apple DJ, Mamalis N, Loftfield K, Googe JM, Novak LC, Kavka-Van Norman D, et al. Complications of intraocular lenses. A historical and histopathological review. Surv Ophthalmol 1984;29:1-54.
106. Nishi O, Nishi K, Fujiwara T, Shirasawa E, Ohmoto Y. Effects of the cytokines on the proliferation of and collagen synthesis by human cataract lens epithelial cells. Br J Ophthalmol 1996;80:63-68.
107. Zaczek A, Zetterstrom C. Posterior capsule opacification after phaocoemulsification in patients with diabetes mellitus. J Cataract Refract Surg 1999;25:233-237.
108. Hayashi K, Hayashi H, Nakao F, Hayashi F. Posterior capsule opacification after cataract surgery in patients with diabetes mellitus. Am J Ophthalmol 2002;134:10-16.
109. Kato S, Oshika T, Numaga J, Hayashi Y, Oshiro M, Yuguchi T, et al. Anterior capsular contraction after cataract surgery in eyes of diabetic patients. Br J Ophthalmol 2001;85:21-23.